Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
EyePoint Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 47.5K | $530K | $11.16 | May 25, 2024 | Direct |
EyePoint Pharmaceuticals, Inc. | Chief Financial Officer | Restricted Stock Units | 15K | $190K | $12.65 | May 25, 2024 | Direct |
EyePoint Pharmaceuticals, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 90K | Jan 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EYPT | EyePoint Pharmaceuticals, Inc. | May 25, 2024 | 3 | -$40.5K | 4 | May 28, 2024 | Chief Financial Officer |
EYPT | EyePoint Pharmaceuticals, Inc. | Feb 9, 2024 | 6 | -$91.9K | 4 | Feb 13, 2024 | Chief Financial Officer |
EYPT | EyePoint Pharmaceuticals, Inc. | Jan 5, 2024 | 5 | -$100K | 4 | Jan 9, 2024 | Chief Financial Officer |
EYPT | EyePoint Pharmaceuticals, Inc. | Oct 16, 2023 | 1 | $0 | 4 | Oct 17, 2023 | Chief Financial Officer |
EYPT | EyePoint Pharmaceuticals, Inc. | Jun 20, 2023 | 1 | $0 | 4 | Jun 22, 2023 | Chief Financial Officer |
EYPT | EyePoint Pharmaceuticals, Inc. | May 25, 2023 | 2 | $0 | 4 | May 30, 2023 | Chief Financial Officer |
EYPT | EyePoint Pharmaceuticals, Inc. | Feb 9, 2023 | 4 | $0 | 4 | Feb 13, 2023 | Chief Financial Officer |
EYPT | EyePoint Pharmaceuticals, Inc. | Jan 6, 2023 | 1 | $0 | 4 | Jan 10, 2023 | Chief Financial Officer |
EYPT | EyePoint Pharmaceuticals, Inc. | Feb 9, 2022 | 5 | -$17.4K | 4 | Feb 11, 2022 | Chief Financial Officer |
EYPT | EyePoint Pharmaceuticals, Inc. | Jun 22, 2021 | 2 | $0 | 4 | Jun 23, 2021 | Chief Financial Officer |